APA (7th ed.) Citation

Karbhari, A., Mosessian, S., Trivedi, K. H., Valla, F., Jacobson, M., Truty, M. J., . . . Goenka, A. H. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Karbhari, Aashna, et al. Gallium-68-labeled Fibroblast Activation Protein Inhibitor-46 PET in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Phase 2, Multicenter, Single Arm, Open Label Non-randomized Study Protocol. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Karbhari, Aashna, et al. Gallium-68-labeled Fibroblast Activation Protein Inhibitor-46 PET in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Phase 2, Multicenter, Single Arm, Open Label Non-randomized Study Protocol. Public Library of Science (PLoS).